RITUXIMAB IN LIFE THREATENING THERAPY RESISTANT PROGRESSIVE INTERSTITIAL PNEUMONITIS
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Pneumonitis
- Focus Therapeutic Use
- Acronyms RITUX-IP
- 25 Apr 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2017.
- 25 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.
- 25 Apr 2017 Status changed from recruiting to active, no longer recruiting.